2017 Winner in CRO Leadership Awards for Second Consecutive Year
Pharm-Olam LLC has been selected as a winner in Life Science Leader magazine’s 2017 CRO Leadership Awards. JUNE 13, 2017 HOUSTON, TX – Pharm-Olam International LLC, an award-winning, multinational, full-service Clinical Research Organization (CRO) serving the biopharmaceutical and medical device industries, today announced the company has been selected as a winner in Life Science Leader magazine’s […]
Pharm-Olam International Adds John Barry as Chief Operating Officer
Pharm-Olam LLC, announced the appointment of John Barry as Chief Operating Officer. MAY 31, 2017 HOUSTON, TX – Pharm-Olam International LLC, a multinational, full-service Clinical Research Organization (CRO) serving the biopharmaceutical and medical device industries, today announced the appointment of John Barry as Chief Operating Officer. As the Chief Operating Officer, Mr. Barry will be responsible […]
Pharm-Olam Webinar: Evolution of Response Evaluation Oncology Trials
Global clinical research experts host an interactive discussion and seminar on the Evolution of Response Evaluation in Oncology Trials. MARCH 23, 2017 Global clinical research experts Yamin “Mo” Khan, PhD, and Dhiraj Abhyankar, MD will host an interactive discussion and seminar on the Evolution of Response Evaluation in Oncology Trials. The free public forum will be held at 11 […]
Pharm-Olam LLC Announces New Addition to Lead Biostatistics Team
Pharm-Olam LLC, announced the appointment of Julia Graz as Senior Director, Biostatistics. FEBRUARY 22, 2017 HOUSTON, TEXAS – Pharm-Olam International LLC, a multinational, full-service Clinical Research Organization (CRO) serving the biopharmaceutical and medical device industries, today announced the appointment of Julia Graz as Senior Director, Biostatistics. Ms. Graz adds over 25 years of progressive pharmaceutical industry […]
Quad-C Management Announces Investment in Pharm-Olam LLC
Quad-C Management, Inc. has closed investment in Pharm-Olam, serving the biopharmaceutical and medical device industries. FEBRUARY 9, 2017 Charlottesville, VA. – Quad-C Management, Inc. (“Quad-C”), a leading middle market private equity firm, today announced it has closed an investment in Pharm-Olam International Ltd., a multinational, full-service clinical research organization (CRO), serving the biopharmaceutical and medical […]
Using Medidata Rave improves Data Management & Reporting Capabilities
Pharm-Olam LLC, announced the deployment of Medidata Rave® to streamline its global Data Management and Reporting services. JANUARY 31, 2017 HOUSTON, TEXAS – January 31, 2017. Pharm-Olam International Ltd., a multinational, full-service clinical research organization (CRO) serving the biopharmaceutical and medical device industries, today announced that it has deployed Medidata Rave (link is external)®—the industry’s leading electronic data […]